117 related articles for article (PubMed ID: 32881774)
1. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, reverses neuroinflammation in lipopolysaccharide-induced mice.
Lu H; Zhang H; Cong Y; Li W; Zhou J; Wu C; Liang F; Li Y
Neuroreport; 2020 Oct; 31(15):1096-1103. PubMed ID: 32881774
[TBL] [Abstract][Full Text] [Related]
2. A novel PPARα agonist propane-2-sulfonic acid octadec-9-enyl-amide inhibits inflammation in THP-1 cells.
Zhao Y; Yan L; Luo XM; Peng L; Guo H; Jing Z; Yang LC; Hu R; Wang X; Huang XF; Wang YQ; Jin X
Eur J Pharmacol; 2016 Oct; 788():104-112. PubMed ID: 27318324
[TBL] [Abstract][Full Text] [Related]
3. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, protects against ischemia-induced brain damage in mice by inhibiting inflammatory responses.
Li Y; Xu L; Zeng K; Xu Z; Suo D; Peng L; Ren T; Sun Z; Yang W; Jin X; Yang L
Brain Behav Immun; 2017 Nov; 66():289-301. PubMed ID: 28736035
[TBL] [Abstract][Full Text] [Related]
4. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, attenuates molecular pathological alterations in learning memory in AD mice.
Li Y; Zhang Y; Wang Q; Wu C; Du G; Zeng Y; Song Z; Jiang X; Jiang X; Zhuo R; Li J
Neurol Res; 2024 May; 46(5):416-425. PubMed ID: 38577889
[TBL] [Abstract][Full Text] [Related]
5. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel peroxisome proliferator-activated receptors α and γ dual agonist, enhances hippocampal neurogenesis and neuroplasticity in rats with cerebral ischaemia.
Li Y; Ren T; Xu L; Wang Y; Yang B; Luo H; Zeng Z; Zhang Y; Du G; Zhu M; Zhou J
Neuroreport; 2019 Dec; 30(18):1299-1306. PubMed ID: 31714482
[TBL] [Abstract][Full Text] [Related]
6. A novel PPARα/γ agonist, propane-2-sulfonic acid octadec-9-enyl-amide, ameliorates insulin resistance and gluconeogenesis in vivo and vitro.
Ren T; Yang WS; Lin Y; Liu JF; Li Y; Yang LC; Zeng KY; Peng L; Liu YJ; Ye ZH; Luo XM; Ke YJ; Diao Y; Jin X
Eur J Pharmacol; 2018 May; 826():1-8. PubMed ID: 29476879
[TBL] [Abstract][Full Text] [Related]
7. Propane-2-sulfonic acid octadec-9-enyl-amide alleviates scopolamine-induced spatial learning and memory deficits in mice.
Li Y; Lu H; Xie S; Cong Y; Wang Y; Zhu M; Zhou J
Biochem Biophys Res Commun; 2020 Aug; 529(2):283-288. PubMed ID: 32703424
[TBL] [Abstract][Full Text] [Related]
8. Effect of propane-2-sulfonic acid octadec-9-enyl-amide on the expression of adhesion molecules in human umbilical vein endothelial cells.
Chen CX; Yang LC; Xu XD; Wei X; Gai YT; Peng L; Guo H; Hao-Zhou ; Wang YQ; Jin X
Eur J Pharmacol; 2015 Jun; 756():15-21. PubMed ID: 25797284
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory mechanism of galangin in lipopolysaccharide-stimulated microglia: Critical role of PPAR-γ signaling pathway.
Choi MJ; Lee EJ; Park JS; Kim SN; Park EM; Kim HS
Biochem Pharmacol; 2017 Nov; 144():120-131. PubMed ID: 28757373
[TBL] [Abstract][Full Text] [Related]
10. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
García C; Gómez-Cañas M; Burgaz S; Palomares B; Gómez-Gálvez Y; Palomo-Garo C; Campo S; Ferrer-Hernández J; Pavicic C; Navarrete C; Luz Bellido M; García-Arencibia M; Ruth Pazos M; Muñoz E; Fernández-Ruiz J
J Neuroinflammation; 2018 Jan; 15(1):19. PubMed ID: 29338785
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory properties of a dual PPARgamma/alpha agonist muraglitazar in in vitro and in vivo models.
Paukkeri EL; Leppänen T; Lindholm M; Yam MF; Asmawi MZ; Kolmonen A; Aulaskari PH; Moilanen E
Arthritis Res Ther; 2013 Apr; 15(2):R51. PubMed ID: 23594962
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine inhibits LPS-induced inflammatory responses through peroxisome proliferator-activated receptor gamma (PPARγ) activation following binding to α
Fujimoto M; Higuchi H; Honda-Wakasugi Y; Miyake S; Nishioka Y; Yabuki-Kawase A; Maeda S; Miyawaki T
Eur J Pharmacol; 2021 Feb; 892():173733. PubMed ID: 33220278
[TBL] [Abstract][Full Text] [Related]
13. Osthole inhibits inflammatory cytokine release through PPARα/γ-mediated mechanisms in LPS-stimulated 3T3-L1 adipocytes.
Wang XL; Shang X; Cui Y; Zhao X; Zhang Y; Xie ML
Immunopharmacol Immunotoxicol; 2015 Apr; 37(2):185-92. PubMed ID: 25689951
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic systemic treatment with peroxisome proliferator-activated receptor α activators on neuroinflammation induced by intracerebral injection of lipopolysaccharide in adult mice.
Wang G; Namura S
Neurosci Res; 2011 Jun; 70(2):230-7. PubMed ID: 21300114
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models.
Lee YJ; Choi DY; Choi IS; Kim KH; Kim YH; Kim HM; Lee K; Cho WG; Jung JK; Han SB; Han JY; Nam SY; Yun YW; Jeong JH; Oh KW; Hong JT
J Neuroinflammation; 2012 Feb; 9():35. PubMed ID: 22339795
[TBL] [Abstract][Full Text] [Related]
16. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.
Orasanu G; Ziouzenkova O; Devchand PR; Nehra V; Hamdy O; Horton ES; Plutzky J
J Am Coll Cardiol; 2008 Sep; 52(10):869-81. PubMed ID: 18755353
[TBL] [Abstract][Full Text] [Related]
17. T33, a novel peroxisome proliferator-activated receptor γ/α agonist, exerts neuroprotective action via its anti-inflammatory activities.
Wang Y; Yang YS; Tang XC; Zhang HY
Acta Pharmacol Sin; 2011 Sep; 32(9):1100-8. PubMed ID: 21804572
[TBL] [Abstract][Full Text] [Related]
18. Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes.
Chistyakov DV; Astakhova AA; Goriainov SV; Sergeeva MG
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339154
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan mediates anti-inflammatory and not cognitive function through PPAR-γ agonism via SARM and MyD88 signaling.
Prathab Balaji S; Vijay Chand C; Justin A; Ramanathan M
Pharmacol Biochem Behav; 2015 Oct; 137():60-8. PubMed ID: 26264163
[TBL] [Abstract][Full Text] [Related]
20. Biochanin A ameliorates the cytokine secretion profile of lipopolysaccharide-stimulated macrophages by a PPARγ-dependent pathway.
Qiu L; Lin B; Lin Z; Lin Y; Lin M; Yang X
Mol Med Rep; 2012 Jan; 5(1):217-22. PubMed ID: 21946955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
